Filing Details
- Accession Number:
- 0001415889-24-027746
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-26 17:00:06
- Reporting Period:
- 2024-11-25
- Accepted Time:
- 2024-11-26 17:00:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1907108 | Lexeo Therapeutics Inc. | LXEO | () | PA |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1193675 | H Paula Cholmondeley | C/O Lexeo Therapeutics, Inc. 345 Park Avenue South, Floor 6 New York NY 10010 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-25 | 15,000 | $6.99 | 30,627 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- 15,627 of the shares are subject to vesting and vest at the following rate: 1/48th of the shares vested or vest in monthly installments commencing on December 1, 2021, subject to the Reporting Person's continuous service.
Billionaire Hedge Funds
